Oribel Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Oribel Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-102,000	Closed	-$49.5M	–	144
2025 Q3	$49.5M	Buy	+102,000	New	+$47.5M	1.55%	22
2025 Q2	–	Sell	-42,200	Closed	-$21M	–	159
2025 Q1	$21M	Buy	+42,200	New	+$22.9M	0.86%	46
2024 Q4	–	Sell	-75,300	Closed	-$46.6M	–	134
2024 Q3	$46.6M	Buy	75,300 +21,000	+39%	+$12.4M	2.05%	18
2024 Q2	$201K	Buy	+54,300	New	+$31.1M	0.03%	42
2023 Q3	–	Sell	-40,300	Closed	-$21M	–	104
2023 Q2	$21M	Buy	+40,300	New	+$21.7M	1.16%	26

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oribel Capital Management's TMO Position: Q4 2025 in Review

Oribel Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 40,400 shares — an estimated $19.6M sold.

Oribel Capital Management first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $59.6M in Q4 2023. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Oribel Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
Oribel Capital Management sold 40,400 Thermo Fisher Scientific shares in Q4 2025, an estimated $19.6M.
Oribel Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
Oribel Capital Management's Thermo Fisher Scientific position peaked at $59.6M in Q4 2023.
2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Oribel Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.